for PPMS: presence of Gd-enhancing lesions on baseline MRI), the age-adjusted sNfL levels after 96 weeks of ocrelizumab in treated RMS patients approached those of a cohort of healthy controls in the two sub-groups with or without baseline disease activity (geometric mean = 4.4 [4.24.6] pg/ml and 4.1 [4.04.3] pg/ml, respectively) [45]
2013;8(9):e74558
doi: 10.1016/j.jdiacomp.2022.108332 138 RosenstockJFriasJJastreboffAMDuYLouJGurbuzSet al
[DOI] [PubMed] [Google Scholar] 35.Bird T.G., Muller M., Boulter L., Vincent D.F., Ridgway R.A., Lopez-Guadamillas E., Lu W.Y., Jamieson T., Govaere O., Campbell A.D., Ferreira-Gonzalez S., Cole A.M., Hay T., Simpson K.J., Clark W., Hedley A., Clarke M., Gentaz P., Nixon C., Bryce S., Kiourtis C., Sprangers J., Nibbs R.J.B., Van Rooijen N., Bartholin L., McGreal S.R., Apte U., Barry S.T., Iredale J.P., Clarke A.R., Serrano M., Roskams T.A., Sansom O.J., Forbes S.J
During embryonic stages, the body relies on specific signaling molecules to drive growth and organization, and reintroducing molecules like T4 later in life may help reawaken those regenerative pathways, particularly following cardiac injury
Among the 50 generated conformations, the optimal docking result was selected based on Gibbs free energy, and further downstream analysis was focused on this highly ranked conformation
